Stratifying breast cancer patients by baseline risk of cardiotoxic complications linked to chemotherapy
A majority of modern antitumor pharmaceuticals are accompanied by cardiotoxicity. The <b>study aims</b> to present practical approaches to stratifying the baseline risk of antitumor therapies' cardiotoxicity in patients newly diagnosed with breast cancer started on anthracyclines an...
Main Authors: | Zhenisgul Tlegenova, Saule Balmagambetova, Bekbolat Zholdin, Gulnara Kurmanalina, Iliada Talipova, Arip Koyshybaev, Dinara Nurmanova, Gulmira Sultanbekova, Mira Baspayeva, Saule Madinova, Kulparshan Kubenova, Ainel Urazova |
---|---|
Format: | Article |
Language: | English |
Published: |
National Scientific Medical Center
2023-06-01
|
Series: | Ķazaķstannyṇ Klinikalyķ Medicinasy |
Subjects: | |
Online Access: | https://www.clinmedkaz.org/download/stratifying-breast-cancer-patients-by-baseline-risk-of-cardiotoxic-complications-linked-to-13325.pdf |
Similar Items
-
Early Diagnosis of Chemotherapy-Linked Cardiotoxicity in Breast Cancer Patients Using Conventional Biomarker Panel: A Prospective Study Protocol
by: Saule Balmagambetova, et al.
Published: (2022-11-01) -
A first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in Kazakhstan
by: Zhenisgul Tlegenova, et al.
Published: (2022-02-01) -
Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan
by: Zhenisgul Tlegenova, et al.
Published: (2023-11-01) -
Comments on new 2022 European Society of Cardiology guidelines on cardioncology
by: Zhenisgul Tlegenova, et al.
Published: (2023-01-01) -
Screening for atrial fibrillation
by: Zhenisgul Tlegenova, et al.
Published: (2018-03-01)